radiofrequency ablation

Radiofrequency Ablation: A Minimally Invasive Alternative for Thyroid Nodules Post-Lobectomy

By MedXY 09/22/2026

Radiofrequency ablation (RFA) provides a safe, effective treatment for thyroid nodules in the remaining lobe after unilateral thyroid lobectomy, offering substantial volume reduction with minimal complications and preserved thyroid function.

Cardiology Neurology news

Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry

By MedXY 08/28/2026

This prospective registry reveals a significantly increased risk of stroke or transient ischemic attack within 30 days after pulsed field ablation compared to radiofrequency ablation for atrial fibrillation, highlighting important safety considerations and the need for careful surveillance.

Diabetes & Endocrinology General Surgery news

Economic Evaluation of Thyroid Radiofrequency Ablation Versus Hemithyroidectomy: A Micro-Costing Perspective in Canadian Healthcare Settings

By MedXY 08/16/2026

This study quantitatively compares the direct healthcare costs of thyroid radiofrequency ablation (RFA) and hemithyroidectomy over one year, revealing cost advantages of RFA driven by reduced facility use, tempered by factors like repeat procedures and potential delayed surgeries.

Diabetes & Endocrinology news Oncology

Thermal Ablation for Low-Risk Papillary Thyroid Cancer in Latin America: Promising Early Outcomes from a Multicenter Study

By MedXY 08/15/2026

A large Latin American study shows radiofrequency ablation is a safe, effective minimally invasive alternative for T1a low-risk papillary thyroid cancer, with excellent tumor disappearance rates and minimal complications over 18 months follow-up.

Cardiology news

Pulsed Field Ablation Matches Radiofrequency in Efficacy but Shows Superior Safety Profile for Paroxysmal Atrial Fibrillation: BEAT PAROX-AF Trial

By MedXY 04/05/2026

The BEAT PAROX-AF trial demonstrates equivalent single-procedure success rates between pulsed field ablation (77.2%) and radiofrequency ablation (77.6%) for paroxysmal atrial fibrillation, while showing a numerically lower safety event rate with PFA (3.4% vs 7.6%).

Clinical Updates General Surgery news Oncology Radiology Specialties

Surgery or Radiofrequency Ablation for Small Hepatocellular Carcinoma: Insights from the SURF Trials

By MedXY 08/07/2025

The SURF trials found no significant difference in survival or recurrence-free outcomes between surgery and radiofrequency ablation for small hepatocellular carcinoma, supporting RFA as a less invasive, equally effective option.

Clinical Updates General Surgery news Oncology Specialties

Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: Insights from the SURF-RCT and SURF-Cohort Trials

By MedXY 08/07/2025

The SURF trials found no significant difference in survival or recurrence between surgery and radiofrequency ablation for small hepatocellular carcinoma, supporting both as valid first-line options.